NORTH AMERICA POSTPARTUM HEMORRHAGE MARKET FORECAST 2017-2025
KEY FINDINGS
The North America Postpartum Hemorrhage market is anticipated to expand from $246 million in the year 2016 to $424 million in the year 2025 growing at a CAGR of 6.36% during the forecasted period 2017-2025. The base year is deliberated to be 2016 and the forecast period is from 2017 to 2025. Increasing awareness among people in developing countries for postpartum treatment and rising rate of postpartum hemorrhage are some of the dominant drivers in the postpartum hemorrhage market. Also, the rapid growth of risk factors in postpartum hemorrhage and educational initiatives by the government and training in regard to women’s health also acts as leading drivers in the postpartum hemorrhage market.
MARKET INSIGHTS
The postpartum hemorrhage market is segmented by type on the basis of Uterine Balloon Tamponade market, by Uniject prefilled Injection system and by Nonpneumatic anti-shock garment type market. The Uterine Balloon Tamponade market is further segmented on the basis of Foley Catheters market, Condom Catheters market and others.
COMPETITIVE INSIGHTS
Major players in the postpartum hemorrhage market are 3RD Stone design, Inc, Bactiguard AB, C.R.Bard,INC, Cook Medical, Inc, Avol Inc, Teleflex Incorporated, Utah medical products, Inc, Becton Dickinson and company, GE Healthcare, Program for Appropriate Technology in Health (PATH), Zoex Niasg, Inpress technologies
The North America Postpartum Hemorrhage market is anticipated to expand from $246 million in the year 2016 to $424 million in the year 2025 growing at a CAGR of 6.36% during the forecasted period 2017-2025. The base year is deliberated to be 2016 and the forecast period is from 2017 to 2025. Increasing awareness among people in developing countries for postpartum treatment and rising rate of postpartum hemorrhage are some of the dominant drivers in the postpartum hemorrhage market. Also, the rapid growth of risk factors in postpartum hemorrhage and educational initiatives by the government and training in regard to women’s health also acts as leading drivers in the postpartum hemorrhage market.
MARKET INSIGHTS
The postpartum hemorrhage market is segmented by type on the basis of Uterine Balloon Tamponade market, by Uniject prefilled Injection system and by Nonpneumatic anti-shock garment type market. The Uterine Balloon Tamponade market is further segmented on the basis of Foley Catheters market, Condom Catheters market and others.
COMPETITIVE INSIGHTS
Major players in the postpartum hemorrhage market are 3RD Stone design, Inc, Bactiguard AB, C.R.Bard,INC, Cook Medical, Inc, Avol Inc, Teleflex Incorporated, Utah medical products, Inc, Becton Dickinson and company, GE Healthcare, Program for Appropriate Technology in Health (PATH), Zoex Niasg, Inpress technologies
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
4. MARKET OVERVIEW
4.1. MARKET DEFINITION AND SCOPE
4.2. MARKET DRIVERS
4.2.1. RISING AWARENESS AMONG PEOPLE IN DEVELOPING COUNTRIES FOR POSTPARTUM TREATMENT
4.2.2. RISING OCCURRENCE OF POSTPARTUM HEMORRHAGE
4.2.3. PROLIFERATION IN POSTPARTUM HEMORRHAGE RISK FACTORS
4.2.4. INCREASING GOVERNMENT EDUCATIONAL INITIATIVES AND TRAINING ABOUT WOMEN’S HEALTH
4.3. MARKET RESTRAINTS
4.3.1. PEOPLE ARE RELUCTANT TO ADOPT UNCONVENTIONAL POSTPARTUM HEMORRHAGE PREVENTIVE DEVICES
4.3.2. HIGH COST OF POSTPARTUM HEMORRHAGE TREATMENT
4.4. MARKET OPPORTUNITIES
4.4.1. RISING DEMAND FROM EMERGING COUNTRIES
4.4.2. TECHNOLOGICAL ADVANCEMENTS
4.5. MARKET CHALLENGES
4.5.1. LOW ACCEPTANCE OF DEVICES IN DEVELOPING COUNTRIES
4.5.2. LACK OF PRODUCT AWARENESS IN UNTAPPED MARKET
4.5.3. EASY AVAILABILITY OF DRUGS IN THE MARKET
5. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY TYPE 2017-2025 ($ MILLION)
5.1. BY UTERINE BALLOON TAMPONADE MARKET 2017-2025 ($ MILLION)
5.1.1. FOLEY CATHETERS MARKET 2017-2025 ($ MILLION)
5.1.2. CONDOM CATHETERS MARKET 2017-2025 ($ MILLION)
5.1.3. OTHERS MARKET 2017-2025 ($ MILLION)
5.2. BY UNIJECT PREFILLED INJECTION SYSTEM 2017-2025 ($ MILLION)
5.3. BY NONPNEUMATIC ANTI-SHOCK GARMENT 2017-2025 ($ MILLION)
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS
6.1.3. BARGAINING POWER OF BUYERS
6.1.4. BARGAINING POWER OF SUPPLIERS
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. KEY BUYING CRITERIA
6.2.1. PRICING
6.2.2. AVAILABILITY
6.2.3. QUALITY
6.2.4. SPECIFICITY
6.3. OPPORTUNITY MATRIX
6.4. VENDOR LANDSCAPE
7. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
7.1. US
7.2. CANADA
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. LIST OF STRAGETIC INITIATIVES
8.3. COMPANY PROFILES
8.3.1. 3RD STONE DESIGN, INC.
8.3.1.1. OVERVIEW
8.3.1.2. PRODUCT PORTFOLIO:
8.3.1.3. SCOT ANALYSIS
8.3.1.4. STRATEGIC ANALYSIS
8.3.2. BACTIGUARD AB
8.3.2.1. OVERVIEW
8.3.2.2. PRODUCT PORTFOLIO:
8.3.2.3. STRATEGIC INITIATIVES:
8.3.2.4. SCOT ANALYSIS
8.3.2.5. STRATEGIC ANALYSIS
8.3.3. C. R. BARD, INC.
8.3.3.1. OVERVIEW
8.3.3.2. PRODUCT PORTFOLIO
8.3.3.3. STRATEGIC INITIATIVES:
8.3.3.4. SCOT ANALYSIS
8.3.3.5. STRATEGIC ANALYSIS
8.3.4. COOK MEDICAL, INC.
8.3.4.1. OVERVIEW
8.3.4.2. PRODUCT PORTFOLIO
8.3.4.3. SCOT ANALYSIS
8.3.4.4. STRATEGIC ANALYSIS
8.3.5. AVOL INC.
8.3.5.1. OVERVIEW
8.3.5.2. PRODUCT PORTFOLIO
8.3.5.3. SCOT ANALYSIS
8.3.5.4. STRATEGIC ANALYSIS
8.3.6. TELEFLEX INCORPORATED
8.3.6.1. OVERVIEW
8.3.6.2. PRODUCT PORTFOLIO
8.3.6.3. STRATEGIC INITIATIVES
8.3.6.4. SCOT ANALYSIS
8.3.6.5. STRATEGIC ANALYSIS
8.3.7. UTAH MEDICAL PRODUCTS, INC.
8.3.7.1. OVERVIEW
8.3.7.2. PRODUCT PORTFOLIO
8.3.7.3. SCOT ANALYSIS
8.3.7.4. STRATEGIC ANALYSIS
8.3.8. BECTON DICKINSON AND COMPANY
8.3.8.1. OVERVIEW
8.3.8.2. PRODUCT PORTFOLIO
8.3.8.3. STRATEGIC INITIATIVES
8.3.8.4. SCOT ANALYSIS
8.3.8.5. STRATEGIC ANALYSIS
8.3.9. GE HEALTHCARE
8.3.9.1. OVERVIEW
8.3.9.2. PRODUCT PORTFOLIO
8.3.9.3. SCOT ANALYSIS
8.3.9.4. STRATEGIC ANALYSIS
8.3.10. PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH (PATH)
8.3.10.1. OVERVIEW
8.3.10.2. PRODUCT PORTFOLIO
8.3.10.3. SCOT ANALYSIS
8.3.10.4. STRATEGIC ANALYSIS
8.3.11. ZOEX NIASG
8.3.11.1. OVERVIEW
8.3.11.2. PRODUCT PORTFOLIO
8.3.11.3. SCOT ANALYSIS
8.3.11.4. STRATEGIC ANALYSIS
8.3.12. INPRESS TECHNOLOGIES
8.3.12.1. OVERVIEW
8.3.12.2. PRODUCT PORTFOLIO
8.3.12.3. SCOT ANALYSIS
8.3.12.4. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICE MARKET BY GEOGRAPHY 2017-2025
TABLE 2 COST GIVEN FOR THE YEAR 2014 IN US $ -
TABLE 3 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY TYPE 2017-2025 ($MILLION)
TABLE 4 NORTH AMERICA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET BY COUNTRIES 2017-2025 ($ MILLION)
FIGURE LIST
FIGURE 1 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICE MARKET BY TYPE 2017-2025 ($ MILLION)
FIGURE 2 RISK FACTORS IN POSTPARTUM HEMORRHAGE
FIGURE 3 COVERAGE OF MATERNAL HEALTH SERVICES
FIGURE 4 CAUSES OF MATERNAL DEATH
FIGURE 5 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY UTERINE BALLOON TAMPONADE 2017-2025 ($ MILLION)
FIGURE 6 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY FOLEY CATHETERS 2017-2025 ($ MILLION)
FIGURE 7 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET IN CONDOM CATHETERS 2017-2025 ($ MILLION)
FIGURE 8 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY OTHERS MARKET 2017-2025 ($ MILLION)
FIGURE 9 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT MARKET BY UNIJECT PREFILLED INJECTION SYSTEM 2017-2025 ($ MILLION)
FIGURE 10 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY NONPNEUMATIC ANTI-SHOCK GARMENT 2017-2025 ($ MILLION)
FIGURE 11 NORTH AMERICA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 12 UNITED STATES POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 13 CANADA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 12 MARKET SHARE OF ANALYSIS OF KEY PLAYERS 2016 (%)
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
4. MARKET OVERVIEW
4.1. MARKET DEFINITION AND SCOPE
4.2. MARKET DRIVERS
4.2.1. RISING AWARENESS AMONG PEOPLE IN DEVELOPING COUNTRIES FOR POSTPARTUM TREATMENT
4.2.2. RISING OCCURRENCE OF POSTPARTUM HEMORRHAGE
4.2.3. PROLIFERATION IN POSTPARTUM HEMORRHAGE RISK FACTORS
4.2.4. INCREASING GOVERNMENT EDUCATIONAL INITIATIVES AND TRAINING ABOUT WOMEN’S HEALTH
4.3. MARKET RESTRAINTS
4.3.1. PEOPLE ARE RELUCTANT TO ADOPT UNCONVENTIONAL POSTPARTUM HEMORRHAGE PREVENTIVE DEVICES
4.3.2. HIGH COST OF POSTPARTUM HEMORRHAGE TREATMENT
4.4. MARKET OPPORTUNITIES
4.4.1. RISING DEMAND FROM EMERGING COUNTRIES
4.4.2. TECHNOLOGICAL ADVANCEMENTS
4.5. MARKET CHALLENGES
4.5.1. LOW ACCEPTANCE OF DEVICES IN DEVELOPING COUNTRIES
4.5.2. LACK OF PRODUCT AWARENESS IN UNTAPPED MARKET
4.5.3. EASY AVAILABILITY OF DRUGS IN THE MARKET
5. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY TYPE 2017-2025 ($ MILLION)
5.1. BY UTERINE BALLOON TAMPONADE MARKET 2017-2025 ($ MILLION)
5.1.1. FOLEY CATHETERS MARKET 2017-2025 ($ MILLION)
5.1.2. CONDOM CATHETERS MARKET 2017-2025 ($ MILLION)
5.1.3. OTHERS MARKET 2017-2025 ($ MILLION)
5.2. BY UNIJECT PREFILLED INJECTION SYSTEM 2017-2025 ($ MILLION)
5.3. BY NONPNEUMATIC ANTI-SHOCK GARMENT 2017-2025 ($ MILLION)
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS
6.1.3. BARGAINING POWER OF BUYERS
6.1.4. BARGAINING POWER OF SUPPLIERS
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. KEY BUYING CRITERIA
6.2.1. PRICING
6.2.2. AVAILABILITY
6.2.3. QUALITY
6.2.4. SPECIFICITY
6.3. OPPORTUNITY MATRIX
6.4. VENDOR LANDSCAPE
7. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)
7.1. US
7.2. CANADA
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. LIST OF STRAGETIC INITIATIVES
8.3. COMPANY PROFILES
8.3.1. 3RD STONE DESIGN, INC.
8.3.1.1. OVERVIEW
8.3.1.2. PRODUCT PORTFOLIO:
8.3.1.3. SCOT ANALYSIS
8.3.1.4. STRATEGIC ANALYSIS
8.3.2. BACTIGUARD AB
8.3.2.1. OVERVIEW
8.3.2.2. PRODUCT PORTFOLIO:
8.3.2.3. STRATEGIC INITIATIVES:
8.3.2.4. SCOT ANALYSIS
8.3.2.5. STRATEGIC ANALYSIS
8.3.3. C. R. BARD, INC.
8.3.3.1. OVERVIEW
8.3.3.2. PRODUCT PORTFOLIO
8.3.3.3. STRATEGIC INITIATIVES:
8.3.3.4. SCOT ANALYSIS
8.3.3.5. STRATEGIC ANALYSIS
8.3.4. COOK MEDICAL, INC.
8.3.4.1. OVERVIEW
8.3.4.2. PRODUCT PORTFOLIO
8.3.4.3. SCOT ANALYSIS
8.3.4.4. STRATEGIC ANALYSIS
8.3.5. AVOL INC.
8.3.5.1. OVERVIEW
8.3.5.2. PRODUCT PORTFOLIO
8.3.5.3. SCOT ANALYSIS
8.3.5.4. STRATEGIC ANALYSIS
8.3.6. TELEFLEX INCORPORATED
8.3.6.1. OVERVIEW
8.3.6.2. PRODUCT PORTFOLIO
8.3.6.3. STRATEGIC INITIATIVES
8.3.6.4. SCOT ANALYSIS
8.3.6.5. STRATEGIC ANALYSIS
8.3.7. UTAH MEDICAL PRODUCTS, INC.
8.3.7.1. OVERVIEW
8.3.7.2. PRODUCT PORTFOLIO
8.3.7.3. SCOT ANALYSIS
8.3.7.4. STRATEGIC ANALYSIS
8.3.8. BECTON DICKINSON AND COMPANY
8.3.8.1. OVERVIEW
8.3.8.2. PRODUCT PORTFOLIO
8.3.8.3. STRATEGIC INITIATIVES
8.3.8.4. SCOT ANALYSIS
8.3.8.5. STRATEGIC ANALYSIS
8.3.9. GE HEALTHCARE
8.3.9.1. OVERVIEW
8.3.9.2. PRODUCT PORTFOLIO
8.3.9.3. SCOT ANALYSIS
8.3.9.4. STRATEGIC ANALYSIS
8.3.10. PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH (PATH)
8.3.10.1. OVERVIEW
8.3.10.2. PRODUCT PORTFOLIO
8.3.10.3. SCOT ANALYSIS
8.3.10.4. STRATEGIC ANALYSIS
8.3.11. ZOEX NIASG
8.3.11.1. OVERVIEW
8.3.11.2. PRODUCT PORTFOLIO
8.3.11.3. SCOT ANALYSIS
8.3.11.4. STRATEGIC ANALYSIS
8.3.12. INPRESS TECHNOLOGIES
8.3.12.1. OVERVIEW
8.3.12.2. PRODUCT PORTFOLIO
8.3.12.3. SCOT ANALYSIS
8.3.12.4. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICE MARKET BY GEOGRAPHY 2017-2025
TABLE 2 COST GIVEN FOR THE YEAR 2014 IN US $ -
TABLE 3 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY TYPE 2017-2025 ($MILLION)
TABLE 4 NORTH AMERICA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET BY COUNTRIES 2017-2025 ($ MILLION)
FIGURE LIST
FIGURE 1 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICE MARKET BY TYPE 2017-2025 ($ MILLION)
FIGURE 2 RISK FACTORS IN POSTPARTUM HEMORRHAGE
FIGURE 3 COVERAGE OF MATERNAL HEALTH SERVICES
FIGURE 4 CAUSES OF MATERNAL DEATH
FIGURE 5 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY UTERINE BALLOON TAMPONADE 2017-2025 ($ MILLION)
FIGURE 6 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY FOLEY CATHETERS 2017-2025 ($ MILLION)
FIGURE 7 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET IN CONDOM CATHETERS 2017-2025 ($ MILLION)
FIGURE 8 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY OTHERS MARKET 2017-2025 ($ MILLION)
FIGURE 9 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT MARKET BY UNIJECT PREFILLED INJECTION SYSTEM 2017-2025 ($ MILLION)
FIGURE 10 NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET BY NONPNEUMATIC ANTI-SHOCK GARMENT 2017-2025 ($ MILLION)
FIGURE 11 NORTH AMERICA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 12 UNITED STATES POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 13 CANADA POSTPARTUM HEMORRHAGE (PPH) TREATMENT DEVICES MARKET 2017-2025 ($ MILLION)
FIGURE 12 MARKET SHARE OF ANALYSIS OF KEY PLAYERS 2016 (%)
